FindTrial
Sign In

TER-2013

DRUG2 trials

Sponsors

Terremoto Biosciences Inc.

Conditions

Breast CancerCervical CancerEndometrial CancerEsophageal Squamous Cell CarcinomaHead and Neck Squamous Cell CarcinomaLung Squamous Cell CarcinomaOvarian CancerSolid Tumor

Phase 1

A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations
RecruitingNCT07109726
Terremoto Biosciences Inc.Breast Cancer, Endometrial Cancer, Ovarian Cancer +5
Start: 2025-09-23End: 2029-02-28Target: 205Updated: 2026-08-21
A Phase 1/2 Trial of TER-2013 in Patients with Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations
Not yet recruitingCTIS2025-525036-34-00
Terremoto Biosciences Inc.Solid Tumours
Target: 88Updated: 2026-08-20